Concepedia

Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R

Romain Schollhammer, Marie–Laure Ranty, Henri de Clermont Gallerande, Florine Cavelier, Ibai E. Valverde, Delphine Vimont, Elif Hindié, Clément Morgat

Cancers · 2023 · 12 citations · 26 references

DOIFull text

Open access

Abstract

Targeting PSMA and NTS<sub>1</sub>/NTS<sub>2</sub> could allow for the detection of all intraprostatic lesions.

References

26

Cancer statistics, 2023

Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.1K citations · Full text

, , +23

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 1.8K citations

, , +12

Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Barış Türkbey et al. · JAMA · 2015 · 1.5K citations · Full text

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Martina Benešová, Martin Schäfer, Ulrike Bauder‐Wüst et al. · Journal of Nuclear Medicine · 2015 · 576 citations

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.

Jean Claude Reubi, Larry K. Kvols, Beatrice Waser et al. · PubMed · 1990 · 380 citations

, , +14